Medtronic (XSWX:MDT) LT-Debt-to-Total-Asset: 0.28 (As of Apr. 2026)

What is Medtronic LT-Debt-to-Total-Asset?

Medtronic XSWX:MDT +1.21% 21 LT-Debt-to-Total-Asset is 0.28 as of Apr. 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Medtronic's long-term debt to total assests ratio for the quarter that ended in Apr. 2026 was 0.28.

Medtronic's long-term debt to total assets ratio increased from Apr. 2025 (0.28) to Apr. 2026 (0.28). It may suggest that Medtronic is progressively becoming more dependent on debt to grow their business.

Medtronic (XSWX:MDT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Medtronic LT-Debt-to-Total-Asset Related Terms

Medtronic LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Medtronic's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic LT-Debt-to-Total-Asset Chart

Medtronic Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

Apr26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.22

0.27

0.28

Medtronic Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.28	0.29	0.30	0.31	0.28

21GF Score

Medtronic PLC XSWX:MDT

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medtronic LT-Debt-to-Total-Asset Calculation

Medtronic's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Apr. 2026 is calculated as

LT Debt to Total Assets (A: Apr. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Apr. 2026 )	/	Total Assets (A: Apr. 2026 )
	=	20613.855	/	73268.853
	=	0.28

Medtronic's Long-Term Debt to Total Asset Ratio for the quarter that ended in Apr. 2026 is calculated as

LT Debt to Total Assets (Q: Apr. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Apr. 2026 )	/	Total Assets (Q: Apr. 2026 )
	=	20613.855	/	73268.853
	=	0.28

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.28 mean?

Medtronic (XSWX:MDT) has a LT-Debt-to-Total-Asset of 0.28 as of Apr. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medtronic and its competitors.

Is Medtronic's LT-Debt-to-Total-Asset too high?

Medtronic's current LT-Debt-to-Total-Asset is 0.28. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Medtronic's LT-Debt-to-Total-Asset compare to SYK and BSX?

Medtronic's LT-Debt-to-Total-Asset of 0.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medtronic and its competitors. Medtronic's current LT-Debt-to-Total-Asset is 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medtronic stock overvalued right now?

Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.28. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current LT-Debt-to-Total-Asset is 0.28 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for XSWX:MDT:

LT-Debt-to-Total-Asset: 0.28
GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
GF Score™: 21/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies SYK BSX EW ABT DXCM GEHC STE ZBH PEN GMED XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 LSE:SN.TSE:7733 PODD MASI BRKR

Other Exchanges MDT:USA MDTN:Mexico 1MDT:Italy 0Y6X:UK 2M6:Germany MDTC34:Brazil MDT:Austria MDT:Argentina

Address Parkmore Business Park West, Building Two, Galway, IRL

Website https://www.medtronic.com

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

21GF Score

Get the complete analysis for XSWX:MDT

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF65.29

Price

CHF80.97

GF Value

View XSWX:MDT Analysis

See LT-Debt-to-Total-Asset data for all stocks →